A Plus Biotechnology Co., Ltd. (TPE:6918)
Taiwan
· Delayed Price · Currency is TWD 74.30
-0.50 (-0.67%)
At close: Apr 29, 2026
A Plus Biotechnology Market Cap
A Plus Biotechnology has a market cap or net worth of 2.50 billion as of April 28, 2026. Its market cap has decreased by -24.28% in one year.
Market Cap
2.50B
Enterprise Value
1.99B
Revenue
835.89M
Ranking
n/a
PE Ratio
14.43
Stock Price
74.30
Market Cap Chart
Since January 6, 2023, A Plus Biotechnology's market cap has increased from 1.52B to 2.50B, an increase of 64.32%. That is a compound annual growth rate of 16.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 2.50B | -15.30% |
| Dec 31, 2025 | 2.96B | 20.95% |
| Dec 31, 2024 | 2.44B | 77.04% |
| Dec 29, 2023 | 1.38B | -9.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dynamic Medical Technologies | 2.34B |
| Medimaging Integrated Solution | 2.71B |
| Applied BioCode | 2.26B |
| Wellell | 2.25B |
| WeLeader Biomedical | 3.06B |
| OK Biotech | 1.85B |
| Taiwan Biomaterial | 1.71B |
| Bonraybio | 4.08B |